A high number of PD-L1+ CD14+ monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitors
Kiyohiro Ando, Kazuyuki Hamada, Midori Shida, Ryotaro Ohkuma, Yutaro Kubota, Atsushi Horiike, Hiroto Matsui, Tomoyuki Ishiguro, Yuya Hirasawa, Hirotsugu Ariizumi, Makoto Watanabe, Rie Onoue, Junji Tsurutani, Kiyoshi Yoshimura, Takuya Tsunoda, Shinichi Kobayashi, Satoshi Wada
Topics & Concepts
CD14Peripheral blood mononuclear cellMedicinePD-L1CD8CD20CancerImmunologyImmune systemT cellCD16MonocyteImmunotherapyCD3Cancer researchAntibodyInternal medicineBiologyBiochemistryIn vitroCancer Immunotherapy and BiomarkersImmune cells in cancerInflammatory Biomarkers in Disease Prognosis